特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

静脈瘤治療市場の分析:治療形態 (硬化療法、静脈内アブレーション、ストリッピング、レーザー、高周波アブレーション) ・セグメントの予測

Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation, Stripping, Laser, Radiofrequency Ablation), And Segment Forecasts To 2024

発行 Grand View Research, Inc. 商品コード 368015
出版日 ページ情報 英文 83 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.84円で換算しております。
静脈瘤治療市場の分析:治療形態 (硬化療法、静脈内アブレーション、ストリッピング、レーザー、高周波アブレーション) ・セグメントの予測 Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation, Stripping, Laser, Radiofrequency Ablation), And Segment Forecasts To 2024
出版日: 2016年07月25日 ページ情報: 英文 83 Pages
概要

世界における静脈瘤治療の市場規模は、2024年までに4億7,500万米ドルに達すると予測されています。

当レポートでは、世界の静脈瘤治療市場について調査し、業界見通しとともに、治療のタイプ別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 静脈瘤治療の展望

  • 静脈瘤治療の区分
  • 静脈瘤治療規模・成長展望
  • 静脈瘤治療:市場ダイナミクス
    • 市場成長促進因子の分析
    • 市場成長抑制因子の分析
  • 主な機会の優先順位付け
  • 産業分析:ポーターのファイブフォース分析
  • 静脈瘤治療の競合情勢
    • 競合情勢:市場ポジショニング分析 (製品、地域プレゼンス、戦略イニシアチブ)
  • 静脈瘤治療のPESTEL分析
  • 静脈瘤治療:将来の展望

第4章 静脈瘤治療タイプの展望

  • 静脈瘤治療のシェア:タイプ別
  • 硬化療法
    • 市場推計
    • 市場予測
  • 静脈内アブレーション
  • ストリッピング

第5章 静脈瘤治療の地域展望

  • 北米
    • 市場推計:タイプ別
    • 市場予測:タイプ別
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • Medtronic plc
    • 企業概要
    • 財務実績
    • 製品ベンチマーキング
    • 戦略イニシアチブ
  • Angio Dynamics, Inc.
  • Biolitec AG
  • Syneron Medical Ltd.
  • Lumenis Ltd.
  • Dornier MedTech GmbH
  • Energist Group
  • Eufoton S. R.L.
  • Vascular Solutions, Inc.
  • Quanta Systems S.p.A.

図表

目次

The global varicose vein treatment market is expected to reach USD 475 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market.

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market.

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.

Further key findings from the report suggest:

In 2015, the sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.

The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.

In 2015, the endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.

In 2016, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region

As of 2016, Europe is characterized by a shift towards less-invasive procedures in treating large varicose veins. It is expected to witness a high growth rate over the forecast period due to the favorable government initiatives and advanced treatment procedures.

The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income

Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.

AngioDynamics, Inc. and MerzPharma GmbH & Co. KGaAin North America established a multi-year relationship to market Asclera for patients with peripheral vascular diseases.In the U.S,.MerzPharma GmbH & Co. KGaAserves as the exclusive distributor of the Asclera Injection. Asclera is approved for the treatment of spider and reticular veins, which showed good improvement in 95% of the patients treated with asclera.

In 2016, Medtronic plc acquired Italian hemodialysis player Bellco, Inc.This acquisition is projected to enable the medical device giant to gain market position in newly formed renal care solution business.

In 2015, Medtronic plc acquired Covidien plc with the objective to move into the additional therapeutic areas, such as chronic venous insufficiency. Covidien plc markets the Venefit procedure that uses radiofrequency energy and minimally invasive radiofrequency ablation to treat the disease.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope &assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Varicose Vein Treatment- Industry snapshot and key buying criteria, 2013 - 2024

Chapter 3. Varicose vein treatment Outlook

  • 3.1. Varicose vein treatment segmentation
  • 3.2. Varicose vein treatment size and growth prospects, 2013 - 2024
  • 3.3. Varicose vein treatment: Market dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Shift towards less-invasive treatment procedures
      • 3.3.1.2. Advanced Varicose vein treatment devices
      • 3.3.1.3. Growth in ageing population
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Risk factors pertaining to varicose vein treatment
  • 3.4. Key opportunities prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. Varicose vein treatment competitive landscape
    • 3.6.1. Competitive landscape: Market position analysis (based on products, regional presence, and strategic initiatives)
  • 3.7. Varicose vein treatment PESTEL analysis, 2015
  • 3.8. Varicose Vein Treatment: Future aspects

Chapter 4. Varicose Vein TypeOutlook

  • 4.1. Varicose vein treatment share by type, 2013 & 2024
  • 4.2. Sclerotherapy
    • 4.2.1. Sclerotherapy market estimates, 2013 - 2015 (USD Million)
    • 4.2.2. Sclerotherapy market forecasts, 2016 - 2024 (USD million)
  • 4.3. Endovenous ablation
    • 4.3.1. Endovenous ablation market estimates, 2013 - 2015 (USD Million)
    • 4.3.2. Endovenous ablation market forecasts, 2016 - 2024 (USD Million)
      • 4.3.2.1. Radio frequency ablation market estimates, 2013 - 2015 (USD Million)
      • 4.3.2.2. Radio frequency ablation market forecasts, 2016 - 2024 (USD Million)
      • 4.3.2.3. Laser ablation market estimates, 2013 - 2015 (USD Million)
      • 4.3.2.4. Laser ablation market estimates, 2013 - 2015 (USD Million)
  • 4.4. Stripping
    • 4.4.1. Stripping market estimates, 2013 - 2015 (USD Million)
    • 4.4.2. Stripping market forecasts, 2016 - 2024 (USD million)

Chapter 5. Varicose vein treatment RegionalOutlook

  • 5.1. North America
    • 5.1.1. Varicose vein treatment market estimates, by type 2013 - 2015 (USD Million)
    • 5.1.2. Varicose vein treatment market forecasts, by type, 2016 - 2024 (USD Million)
      • 5.1.2.1. U.S.
      • 5.1.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.1.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.1.2.2. Canada
      • 5.1.2.2.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.1.2.2.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
  • 5.2. Europe
    • 5.2.1. Varicose vein treatment market estimates, by type, 2013 - 2015 (USD Million)
    • 5.2.2. Varicose vein treatment market forecasts, by type, 2016 - 2024 (USD Million)
      • 5.2.2.1. UK
      • 5.2.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.2.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.2.2.2. Germany
      • 5.2.2.2.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.2.2.2.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.2.2.3. France
      • 5.2.2.3.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.2.2.3.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
  • 5.3. Asia Pacific
    • 5.3.1. Varicose vein treatment market estimates, by type 2013 - 2015 (USD Million)
    • 5.3.2. Varicose vein treatment market forecasts, by type, 2016 - 2024 (USD Million)
      • 5.3.2.1. India
      • 5.3.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.3.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.3.2.2. China
      • 5.3.2.2.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.3.2.2.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.3.2.3. Japan
      • 5.3.2.3.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.3.2.3.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
  • 5.4. Latin America
    • 5.4.1. Varicose vein treatment market estimates, by type, 2013 - 2015 (USD Million)
    • 5.4.2. Varicose vein treatment forecasts, by type, 2016 - 2024 (USD Million)
      • 5.4.2.1. Mexico
      • 5.4.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.4.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
      • 5.4.2.2. Brazil
      • 5.4.2.2.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.4.2.2.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)
  • 5.5. MEA
    • 5.5.1. Varicose vein treatment market estimates, by type, 2013-2015 (USD Million)
    • 5.5.2. Varicose vein treatment market forecasts, by type, 2016 - 2024 (USD Million)
      • 5.5.2.1. South Africa
      • 5.5.2.1.1. Varicose vein treatment markete stimates, 2013 - 2015 (USD Million)
      • 5.5.2.1.2. Varicose vein treatment market forecasts, 2016 - 2024 (USD Million)

Chapter 6. CompetitiveLandscape

  • 6.1. Medtronic plc
    • 6.1.1. Company Overview
    • 6.1.2. Financial Performance
    • 6.1.3. Product Benchmarking
    • 6.1.4. Strategic Initiatives
  • 6.2. Angio Dynamics, Inc.
    • 6.2.1. Company Overview
    • 6.2.2. Financial Performance
    • 6.2.3. Product Benchmarking
    • 6.2.4. Strategic Initiatives
  • 6.3. Biolitec AG
    • 6.3.1. Company Overview
    • 6.3.2. Financial Performance
    • 6.3.3. Product Benchmarking
    • 6.3.4. Strategic Initiatives
  • 6.4. Syneron Medical Ltd.
    • 6.4.1. Company Overview
    • 6.4.2. Financial Performance
    • 6.4.3. Product Benchmarking
    • 6.4.4. Strategic Initiatives
  • 6.5. Lumenis Ltd.
    • 6.5.1. Company Overview
    • 6.5.2. Financial Performance
    • 6.5.3. Product Benchmarking
    • 6.5.4. Strategic Initiatives
  • 6.6. Dornier MedTech GmbH
    • 6.6.1. Company Overview
    • 6.6.2. Financial Performance
    • 6.6.3. Product Benchmarking
    • 6.6.4. Strategic Initiatives
  • 6.7. Energist Group
    • 6.7.1. Company Overview
    • 6.7.2. Financial Performance
    • 6.7.3. Product Benchmarking
    • 6.7.4. Strategic Initiatives
  • 6.8. Eufoton S. R.L.
    • 6.8.1. Company Overview
    • 6.8.2. Financial Performance
    • 6.8.3. Product Benchmarking
    • 6.8.4. Strategic Initiatives
  • 6.9. Vascular Solutions, Inc.
    • 6.9.1. Company Overview
    • 6.9.2. Financial Performance
    • 6.9.3. Product Benchmarking
    • 6.9.4. Strategic Initiatives
  • 6.10. Quanta Systems S.p.A.
    • 6.10.1. Company Overview
    • 6.10.2. Financial Performance
    • 6.10.3. Product Benchmarking
    • 6.10.4. Strategic Initiatives

List of Tables

  • TABLE 1: Varicose vein treatment Market - Industry Snapshot &Key Buying Criteria, 2012 - 2022
  • TABLE 2: Global Varicose vein treatment market, by region, 2013 - 2024 (USD Million)
  • TABLE 3: Global Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 6: Varicose vein treatment - Key market driver analysis
  • TABLE 7: Varicose vein treatment - Key market restraint analysis
  • TABLE 8: North America Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 9: North America Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 1: U.S. Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 1: Canada Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 12: Europe Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 13: Europe Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 14: UK Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 15: Germany Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 16: France Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 17: Asia Pacific Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 18: AsiaPacific Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 19: Japan Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 20: China Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 21: India Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 22: Latin America Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 23: Latin America Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 24: Brazil Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 25: Mexico Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 26: MEA Varicose vein treatment market, by country, 2013 - 2024 (USD Million)
  • TABLE 27: MEA Varicose vein treatment market, by type, 2013 - 2024 (USD Million)
  • TABLE 28: South Africa Varicose vein treatment market, by type, 2013 - 2024 (USD Million)